ImmuCell Corp
ICCCBuild a strategy around ICCC
ImmuCell Corp AI Insights
Informational only. Not investment advice.Snapshot
- Positive operating income (2.3M TTM, 8.4% margin) vs industry median of -20M - rare profitability in biotech/pharma sector[Operating Income TTM]
- Inventory at 9.8M (58% of current assets) with 35% of revenue tied up - potential obsolescence or demand mismatch risk[Inventory]
- R&D at 3.1M TTM (11% of revenue) while maintaining profitability - disciplined spend vs peers burning cash[Research and Development TTM]
Watch Triggers
- Inventory: Exceeds 40% of revenue or grows faster than sales — Current 35% of revenue already elevated; further buildup signals demand issues
- Operating Margin TTM: Falls below 5% — Thin margin buffer; small revenue miss could flip to losses
- Long Term Debt: Increases above 15M or refinancing at higher rates — 11.9M debt at current rates manageable; higher rates pressure thin FCF
Bull Case
One of few profitable small-cap pharma names: ROE 8.3%, ROA 5.2%, ROIC 5.4% TTM - all positive vs deeply negative industry medians (-40%, -31%, -32%)
Asset-heavy model (PP&E 28.8M, 63% of assets) creates barriers; now cash flow positive (2.0M CFO, 715K FCF TTM) after capex cycle
Bear Case
Micro-cap (61.5M market cap) with 11K daily volume - illiquid, wide spreads, difficult to exit positions at scale
P/E of 28.4x vs industry median 20.6x - premium valuation for a company with sub-30M revenue and limited growth runway
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage ICCC's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Margin expansion likely as fixed cost leverage improves on 8% 5Y revenue CAGR
- Operating margin 8.4% with room to scale
- PP&E of 28.8M now generating positive returns
- Interest expense (461K) manageable at 0.46 D/E
Valuation Context
Caveats
Public Strategies Rankings
See how ImmuCell Corp ranks across different investment strategies.
Leverage ICCC's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
ICCC Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$72.37M | — | ||
$81.76M | — | ||
0.00 | — | ||
$27.64M | +4.3% | — | |
$-0.12 | — | ||
5.97% | +12.2% | — | |
-3.76% | +4.4% | — | |
$1.22M | — | ||
-3.81% | +4.4% | — | |
Beta 5Y (Monthly) | unknown | — |
ICCC Dividend History
ICCC Stock Splits
ICCC SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
03/30/26 | 12/31/25 | 10-K | |
11/13/25 | 09/30/25 | 10-Q | |
08/14/25 | 06/30/25 | 10-Q | |
05/14/25 | 03/31/25 | 10-Q | |
03/28/25 | 12/31/24 | Unknown | |
11/13/24 | 09/30/24 | 10-Q | |
08/13/24 | 06/30/24 | 10-Q | |
05/14/24 | 03/31/24 | 10-Q | |
04/01/24 | 12/31/23 | 10-K | |
11/13/23 | 09/30/23 | 10-Q | |
08/10/23 | 06/30/23 | 10-Q | |
05/11/23 | 03/31/23 | 10-Q | |
03/29/23 | 12/31/22 | 10-K | |
11/21/22 | 09/30/22 | 10-Q | |
08/11/22 | 06/30/22 | 10-Q | |
05/12/22 | 03/31/22 | 10-Q | |
03/30/22 | 12/31/21 | 10-K | |
11/15/21 | 09/30/21 | 10-Q | |
11/21/22 | 06/30/21 | 10-Q/A | |
08/12/21 | 06/30/21 | 10-Q | |
11/21/22 | 03/31/21 | 10-Q/A | |
05/13/21 | 03/31/21 | 10-Q | |
03/30/21 | 12/31/20 | 10-K | |
11/12/20 | 09/30/20 | 10-Q | |
08/12/20 | 06/30/20 | 10-Q | |
05/13/20 | 03/31/20 | 10-Q | |
03/27/20 | 12/31/19 | 10-K | |
11/12/19 | 09/30/19 | 10-Q | |
08/12/19 | 06/30/19 | 10-Q | |
05/13/19 | 03/31/19 | 10-Q | |
03/22/19 | 12/31/18 | 10-K | |
11/13/18 | 09/30/18 | 10-Q | |
08/13/18 | 06/30/18 | 10-Q | |
05/14/18 | 03/31/18 | 10-Q | |
03/29/18 | 12/31/17 | 10-K | |
11/13/17 | 09/30/17 | 10-Q | |
08/14/17 | 06/30/17 | 10-Q | |
05/11/17 | 03/31/17 | 10-Q | |
03/30/17 | 12/31/16 | 10-K | |
11/10/16 | 09/30/16 | 10-Q | |
08/11/16 | 06/30/16 | 10-Q | |
05/11/16 | 03/31/16 | 10-Q | |
03/25/16 | 12/31/15 | 10-K | |
11/12/15 | 09/30/15 | 10-Q | |
08/13/15 | 06/30/15 | 10-Q | |
05/12/15 | 03/31/15 | 10-Q | |
03/26/15 | 12/31/14 | 10-K | |
11/12/14 | 09/30/14 | 10-Q | |
08/13/14 | 06/30/14 | 10-Q | |
05/14/14 | 03/31/14 | 10-Q | |
03/26/14 | 12/31/13 | 10-K | |
11/13/13 | 09/30/13 | 10-Q | |
08/13/13 | 06/30/13 | 10-Q | |
05/14/13 | 03/31/13 | 10-Q | |
03/28/13 | 12/31/12 | 10-K | |
11/13/12 | 09/30/12 | 10-Q | |
08/13/12 | 06/30/12 | 10-Q | |
05/14/12 | 03/31/12 | 10-Q | |
03/27/12 | 12/31/11 | 10-K | |
11/14/11 | 09/30/11 | 10-Q | |
01/08/13 | 09/30/11 | 10-Q/A | |
08/15/11 | 06/30/11 | 10-Q | |
01/08/13 | 06/30/11 | 10-Q/A | |
05/16/11 | 03/31/11 | 10-Q | |
01/08/13 | 03/31/11 | 10-Q/A | |
03/28/11 | 12/31/10 | 10-K | |
11/14/11 | 09/30/10 | 10-Q | |
08/16/10 | 06/30/10 | 10-Q | |
05/06/10 | 03/31/10 | 10-Q | |
03/29/10 | 12/31/09 | 10-K | |
11/08/10 | 09/30/09 | 10-Q | |
11/04/09 | 09/30/09 | 10-Q | |
08/04/09 | 06/30/09 | 10-Q | |
05/05/09 | 03/31/09 | 10-Q | |
03/27/09 | 12/31/08 | 10-K | |
11/04/08 | 09/30/08 | 10-Q | |
08/04/08 | 06/30/08 | 8-K | |
05/07/08 | 03/30/08 | Unknown | -- |
12/31/07 | 12/31/07 | 10KSB | |
09/30/07 | 09/30/07 | 10QSB | |
06/30/07 | 06/30/07 | 10QSB | |
03/31/07 | 03/30/07 | Unknown | -- |
12/31/06 | 12/31/06 | 10KSB | |
09/30/06 | 09/30/06 | 10QSB | |
06/30/06 | 06/30/06 | 10QSB | |
03/31/06 | 03/30/06 | Unknown | -- |
03/23/06 | 12/31/05 | 10-K | |
11/09/05 | 09/30/05 | 10-Q | |
07/29/05 | 06/30/05 | 8-K | |
05/12/05 | 03/30/05 | Unknown | -- |
03/29/05 | 12/31/04 | 10-K | |
11/10/04 | 09/30/04 | 10-Q | |
08/10/04 | 06/30/04 | 10-Q | |
05/13/04 | 03/30/04 | Unknown | -- |
03/29/04 | 12/31/03 | 10-K | |
11/12/03 | 09/30/03 | 10-Q | |
08/14/03 | 06/30/03 | 10-Q | |
05/15/03 | 03/30/03 | Unknown | -- |
03/31/03 | 12/31/02 | 10-K | |
11/14/02 | 09/30/02 | 10-Q | |
08/13/02 | 06/30/02 | 10-Q | |
05/14/02 | 03/30/02 | Unknown | -- |
03/29/02 | 12/31/01 | 10-K405 | |
11/13/01 | 09/30/01 | 4 | |
08/14/01 | 06/30/01 | 10-Q | |
05/15/01 | 03/30/01 | Unknown | -- |
03/30/01 | 12/31/00 | 10-K | |
11/13/00 | 09/30/00 | 10-Q | |
08/10/00 | 06/30/00 | 10-Q | |
05/12/00 | 03/30/00 | Unknown | -- |